argenx SE
Change company Symbol lookup
Select an option...
ARGX argenx SE
LULU Lululemon Athletica Inc
APT Alpha Pro Tech Ltd
PTC PTC Inc
AIC Arlington Asset Investment Corp
PSAGW Property Solutions Acquisition Corp II *W EXP 03/01/2026
AMZN Amazon.com Inc
GSK GlaxoSmithKline PLC
TSLA Tesla Inc
MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
Go

Health Care : Biotechnology | Mid Cap Growth
Based in Netherlands
Company profile

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Postmarket

Last Trade
Delayed
$293.74
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$293.74
Day's Change
-1.41 (-0.48%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
297.45
Day's Low
292.00
Volume
(Below Average)
Volume:
120,864

10-day average volume:
139,587
120,864

Microsoft Corp. Stock Underperforms Tuesday When Compared To Competitors

4:32 pm ET September 28, 2021 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Microsoft Corp. (MSFT) slipped 3.62% to $283.52 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 2.04% to 4,352.63 and Dow Jones Industrial Average falling 1.63% to 34,299.99. This was the stock's third consecutive day of losses. Microsoft Corp. closed $22.32 below its 52-week high ($305.84), which the company achieved on August 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Apple Inc. (AAPL) fell 2.38% to $141.91, Alphabet Inc. Cl A (GOOGL) fell 3.72% to $2,716.60, and SAP SE ADR (SAP.XE) fell 3.46% to $137.57. Trading volume (42.4 M) eclipsed its 50-day average volume of 21.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 28, 2021.

-MarketWatch Automation

	

(END) Dow Jones Newswires

September 28, 2021 16:32 ET (20:32 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.